TY - JOUR
T1 - Diagnosis and management of high-risk breast lesions
AU - Parijatham, S. Thomas
N1 - Publisher Copyright:
© National Comprehensive Cancer Network, Inc.
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS) are nonmalignant breast lesions that confer a 4- to 10-fold increased risk for breast cancer in women. Often, AH and LCIS are diagnosed through breast biopsy due to a mammographic or palpable finding. Although AH and LCIS are benign breast disease, further management is necessary due to their high-risk nature and premalignant potential. Over the decades, management of AH and LCIS has changed as more is learned about these disease processes. This review explores the studies evaluating the risk for breast cancer in women with AH or LCIS and the clinical management of these lesions, which can include a combination of surgical excision, surveillance, and risk-reduction therapy.
AB - Atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS) are nonmalignant breast lesions that confer a 4- to 10-fold increased risk for breast cancer in women. Often, AH and LCIS are diagnosed through breast biopsy due to a mammographic or palpable finding. Although AH and LCIS are benign breast disease, further management is necessary due to their high-risk nature and premalignant potential. Over the decades, management of AH and LCIS has changed as more is learned about these disease processes. This review explores the studies evaluating the risk for breast cancer in women with AH or LCIS and the clinical management of these lesions, which can include a combination of surgical excision, surveillance, and risk-reduction therapy.
UR - http://www.scopus.com/inward/record.url?scp=85056651380&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056651380&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2018.7099
DO - 10.6004/jnccn.2018.7099
M3 - Review article
C2 - 30442737
AN - SCOPUS:85056651380
SN - 1540-1405
VL - 16
SP - 1391
EP - 1396
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 11
ER -